Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Historical Holders from Q2 2019 to Q3 2025

Symbol
ARCT on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
25.8M
Holdings value
$476M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
134
Number of buys
69
Number of sells
-67
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BALYASNY ASSET MANAGEMENT L.P. 8.04% $40.3M 2.18M Balyasny Asset Management L.P. 30 Sep 2025
BlackRock, Inc. 7.8% $27.2M 2.1M BlackRock, Inc. 31 Mar 2025
Sumitomo Mitsui Trust Group, Inc. 7.2% +1.43% $35.9M $401K 1.95M +1.13% Sumitomo Mitsui Trust Group, Inc. 30 Sep 2025
Amova Asset Management Americas, Inc. 7.2% +1.43% $35.9M $401K 1.95M +1.13% Amova Asset Management Americas, Inc. 30 Sep 2025
VANGUARD GROUP INC 6.67% $23.6M 1.81M The Vanguard Group 30 Jun 2025
ARK Investment Management LLC 6.32% $22.3M 1.72M ARK Investment Management LLC 30 Jun 2025
STATE STREET CORP 4.9% $17.1M 1.33M STATE STREET CORPORATION 31 Dec 2024

Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 25.8M $476M +$6.87M $18.43 134
2025 Q2 25.7M $335M -$6.83M $13.01 140
2025 Q1 26.6M $281M -$6.2M $10.59 141
2024 Q4 26.6M $451M +$561K $16.97 144
2024 Q3 26.3M $609M -$9.22M $23.21 163
2024 Q2 26.3M $640M -$34.9M $24.35 169
2024 Q1 27.2M $918M +$63M $33.77 176
2023 Q4 25.4M $802M +$9.91M $31.53 165
2023 Q3 25.2M $643M +$38.2M $25.55 146
2023 Q2 23.6M $678M +$11.5M $28.68 143
2023 Q1 23.3M $558M +$17.2M $23.97 124
2022 Q4 22.6M $384M +$11.5M $16.96 111
2022 Q3 22.2M $328M -$1.83M $14.82 106
2022 Q2 20.6M $334M +$9.25M $15.74 116
2022 Q1 21.5M $578M +$37M $26.96 122
2021 Q4 20M $736M +$29.4M $37.01 133
2021 Q3 19.1M $909M -$50.3M $47.78 150
2021 Q2 20.5M $694M +$36.7M $33.84 133
2021 Q1 18.8M $776M -$48.9M $41.30 153
2020 Q4 19.9M $864M +$70.3M $43.38 131
2020 Q3 18.2M $783M +$222M $42.90 127
2020 Q2 12.9M $606M +$389M $46.74 112
2020 Q1 4.74M $65.7M +$2.32M $13.59 53
2019 Q4 4.55M $50.1M -$173K $10.87 49
2019 Q3 4.61M $47.3M +$27.9M $10.27 39
2019 Q2 1.88M $17.7M +$17.7M $9.44 20